BioComp Pharma has a growing portfolio of generic and therapeutic alternative products across a variety of therapeutic categories.
We have an active research and development pipeline that points to further growth, particularly in areas of limited competition and intensive technology.

BioComp Pharma also commercializes products for other companies who don’t have, or don’t want, the necessary commercial and distribution infrastructure. This allows BioComp to act as a single point of commercial contact for the variety of products we distribute. Should your company be interested in getting your product to market, please contact us at

Any reference to “brand comparison” or other comparative or “generic” language presented herein is not a claim of therapeutic equivalency but in fact means the following: “Based on active ingredients, BioComp’s product competes with the indicated brand names and NDC numbers; provided, however, that: (1) all prescription substitutions and/or recommendations using BioComp’s product shall be made subject to state and federal laws, if appropriate; (2) BioComp’s product is not an Orange Book product; and (3) BioComp’s product has not undergone FDA therapeutic equivalency or other equivalency testing.”